Billy Deitch is a seasoned investment professional currently serving as a Partner at Oak HC/FT since January 2018. Deitch is actively involved as an investor in several healthcare technology companies, including Candid Health, Mendel.ai, DispatchHealth, Brightline, and Everside Health, the latter having merged with Marathon Health. Previous investment roles include involvement with Olive, which resulted in a successful exit, and OODA Health, acquired by Cedar. Deitch also held board positions at Dynamo Software and QGenda, both of which were acquired by prominent firms. Educational credentials include a Master of Business Administration from Stanford University Graduate School of Business and a Bachelor of Arts in History from Yale University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices